BR112016004375A2 - acylamino acids production method - Google Patents

acylamino acids production method

Info

Publication number
BR112016004375A2
BR112016004375A2 BR112016004375A BR112016004375A BR112016004375A2 BR 112016004375 A2 BR112016004375 A2 BR 112016004375A2 BR 112016004375 A BR112016004375 A BR 112016004375A BR 112016004375 A BR112016004375 A BR 112016004375A BR 112016004375 A2 BR112016004375 A2 BR 112016004375A2
Authority
BR
Brazil
Prior art keywords
amino acid
acyltransferase
recombinant
production method
acid
Prior art date
Application number
BR112016004375A
Other languages
Portuguese (pt)
Inventor
Wolter Jan
Corthals Jasmin
Grammann Katrin
Reinecke Liv
Olfert Maik
Potgrave Nicole
Schaffer Steffen
Haas Thomas
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of BR112016004375A2 publication Critical patent/BR112016004375A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01065—Bile acid-CoA:amino acid N-acyltransferase (2.3.1.65)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01086—Fatty-acyl-CoA synthase (2.3.1.86)

Abstract

resumo da patente de invenção para: "método de produção de acilaminoácidos". a presente invenção refere-se a uma célula que expressa uma aminoácido n-aciltransferase, a qual é de preferência recombinante, e uma acil-coa sintetase, a qual é preferencialmente recombinante, tendo a célula uma capacidade de degradação de ácidos gordos reduzida, a um método de produção de acilaminoácidos que compreende a etapa de pôr em contato um aminoácido e um acil-coa na presença de uma aminoácido n-aciltransferase, a qual é de preferência isolada e/ou recombinante, em que a aminoácido n-aciltransferase é de preferência uma aminoácido n-aciltransferase humana, ou a cultura da célula e uma mistura reacional composta por uma aminoácido n-aciltransferase, a qual é de preferência isolada e/ou recombinante, uma acil-coa sintetase, a qual é de preferência isolada e/ou recombinante, um aminoácido e quer ácido gordo-coa ou um ácido gordo e uma acil-coa sintetase.Patent Summary for: "Acylamino Acid Production Method". The present invention relates to a cell expressing an amino acid n-acyltransferase, which is preferably recombinant, and an acylcoacetetase, which is preferably recombinant, the cell having a reduced fatty acid degradation capacity. an acylamino acid production method comprising the step of contacting an amino acid and an acylco in the presence of an amino acid n-acyltransferase, which is preferably isolated and / or recombinant, wherein the amino acid n-acyltransferase is preferably a human n-acyltransferase amino acid, or cell culture and a reaction mixture composed of an n-acyltransferase amino acid, which is preferably isolated and / or recombinant, an acylcoacetetase, which is preferably isolated and / or recombinant, an amino acid and either fatty acid or a fatty acid and an acylco synthetase.

BR112016004375A 2013-08-27 2014-08-25 acylamino acids production method BR112016004375A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20130181841 EP2843043A1 (en) 2013-08-27 2013-08-27 A method for producing acyl amino acids
EP20140169650 EP2842542A1 (en) 2013-08-27 2014-05-23 A method for producing acyl amino acids
PCT/EP2014/067990 WO2015028423A1 (en) 2013-08-27 2014-08-25 A method for producing acyl amino acids

Publications (1)

Publication Number Publication Date
BR112016004375A2 true BR112016004375A2 (en) 2017-10-17

Family

ID=49029032

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016004375A BR112016004375A2 (en) 2013-08-27 2014-08-25 acylamino acids production method

Country Status (6)

Country Link
US (1) US20160272950A1 (en)
EP (3) EP2843043A1 (en)
JP (1) JP2016528904A (en)
CN (1) CN105813625A (en)
BR (1) BR112016004375A2 (en)
WO (1) WO2015028423A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
EP2746400A1 (en) 2012-12-21 2014-06-25 Evonik Industries AG Preparation of amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof
EP2759598A1 (en) 2013-01-24 2014-07-30 Evonik Industries AG Process for preparing alpha, omega alkanediols
EP2944697A1 (en) 2014-05-13 2015-11-18 Evonik Degussa GmbH Method of producing nylon
DK3155102T3 (en) 2014-06-11 2023-01-30 Univ Duke COMPOSITIONS AND METHODS FOR RAPID AND DYNAMIC FLOW REGULATION USING SYNTHETIC METABOLIC VALVES
EP3081639A1 (en) * 2015-04-14 2016-10-19 Evonik Degussa GmbH Acyl amino acid production
EP3091080A1 (en) * 2015-05-05 2016-11-09 Evonik Degussa GmbH Process for producing acyl amino acids employing lipases
CN108138121B (en) * 2015-07-22 2022-04-19 纳幕尔杜邦公司 High-level production of long-chain dicarboxylic acids by microorganisms
WO2017102952A1 (en) 2015-12-17 2017-06-22 Evonik Degussa Gmbh A genetically modified acetogenic cell
JP2019523271A (en) 2016-07-27 2019-08-22 エボニック デグサ ゲーエムベーハーＥｖｏｎｉｋ Ｄｅｇｕｓｓａ ＧｍｂＨ N-acetylhomoserine
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
MY193581A (en) 2017-02-21 2022-10-19 Univ Duke Compositions and methods for robust dynamic metabolic control
WO2018157150A1 (en) 2017-02-27 2018-08-30 Duke University In vivo protein n-acylation
EP3778912A4 (en) 2018-04-13 2022-01-26 Ajinomoto Co., Inc. Method for producing n-acyl-amino group-containing compound
US11203744B2 (en) 2018-06-21 2021-12-21 Duke University Compositions and methods for the production of pyruvic acid and related products using dynamic metabolic control
CN114761554A (en) 2019-10-10 2022-07-15 味之素株式会社 Modified enzyme having N-acylation activity
KR102207867B1 (en) * 2020-01-21 2021-01-26 씨제이제일제당 주식회사 Method for producing L-amino acids using microorganisms containing NADP dependent glyceraldehyde-3-phosphate dehydrogenase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141602B2 (en) 1973-12-12 1976-11-11
GB8918709D0 (en) * 1989-08-16 1989-09-27 Unilever Plc Cosmetic composition
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
US5734070A (en) 1994-02-17 1998-03-31 Degussa Aktiengesellschaft Hardening of unsaturated fats, fatty acids or fatty acid esters
US7217856B2 (en) * 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
RU2212447C2 (en) 2000-04-26 2003-09-20 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" Strain escherichia coli as producer of amino acid (variants) and method for preparing amino acid (variants)
US7981685B2 (en) * 2007-04-16 2011-07-19 Modular Genetics, Inc. Generation of acyl amino acids
WO2010127318A2 (en) * 2009-05-01 2010-11-04 The Regents Of The University Of California Product of fatty acid esters from biomass polymers
EP2415451A1 (en) * 2010-08-05 2012-02-08 KPSS-Kao Professional Salon Services GmbH Cleansing composition
AU2011294798B2 (en) * 2010-08-24 2015-06-11 North-West University Recombinant therapeutic glycine N-acyltransferase
SG11201501013PA (en) 2012-08-10 2015-04-29 Opx Biotechnologies Inc Microorganisms and methods for the production of fatty acids and fatty acid derived products
EP2970928A4 (en) * 2013-03-15 2017-02-15 Modular Genetics, Inc. Generation of acyl amino acids

Also Published As

Publication number Publication date
JP2016528904A (en) 2016-09-23
US20160272950A1 (en) 2016-09-22
WO2015028423A1 (en) 2015-03-05
EP3038595A1 (en) 2016-07-06
CN105813625A (en) 2016-07-27
EP2843043A1 (en) 2015-03-04
EP2842542A1 (en) 2015-03-04
EP3038595B1 (en) 2019-08-14

Similar Documents

Publication Publication Date Title
BR112016004375A2 (en) acylamino acids production method
CL2017002184A1 (en) Composition comprising sialillactose for use in improving learning skills and memory function.
BR112015013525A2 (en) a method for producing a fusion protein as well as a composition comprising a fusion protein
PE20151765A1 (en) FORMULAS BASED ON HYDROLYZED AMINO ACID AND PROTEIN WITH A STABLE EMULSION SYSTEM
BR112019006706A2 (en) improved methods for assessing gfap status in patient samples
BR112013016447A2 (en) Production method of recombinant glycoproteins with increased circulatory half-life in mammalian cells
BR112014030682A2 (en) differentiation of human embryonic stem cells into endocrine pancreatic cells
BR112015017307A2 (en) compositions of low acid species and methods for their production and use
BR112012020372A2 (en) "human csf-1r binding body, pharmaceutical composition nucleic acid expression vectors, host cell and method for producing a recombinant antibody
BR112015021495A2 (en) integrated continuous manufacturing of therapeutic protein drug substances
CL2014003110A1 (en) Anti-fcrn antibody; sequences that encode it; vector; host cell; production process; pharmaceutical composition comprising it; use for the treatment of autoimmune disease; and assay to test the ability of an antibody to block human fcrn activity.
CL2015000757A1 (en) A protein
BR112014018630A2 (en) bleaching of chondroitin sulfate glycans
BR112015003591A8 (en) USES OF LYS-C AND METHODS FOR MANUFACTURING A PROTEOLYTHICALLY PROCESSED POLYPEPTIDE
BR112015022443A2 (en) method for the extraction of protein from oilseeds
BR112014023792A2 (en) loaded nutrient proteins and methods
BR112017011542A2 (en) oleic acid production in yeast
CL2011003003A1 (en) Reconstituted surfactant composition comprising a native surfactant protein c-analog polypeptide, a native surfactant protein-b-analog polypeptide, a monounsaturated phospholipid, and a saturated phospholipid, useful for the treatment of respiratory distress syndrome.
BR112016014756A8 (en) sealant formulation comprising fibrinogen and zymogens, their method of manufacture, container and use
AR084760A1 (en) PROCESS FOR ISOLATING A PROTEIN COMPOSITION AND A FAT COMPOSITION FROM MEAT CUTS
BR112015021681A2 (en) binding proteins for pcsk9
BR112016027871A2 (en) composition to improve memory, learning function and / or cognitive function
BR112014028588A8 (en) polypeptide, method of producing a polypeptide comprising the bcn group, method of producing a polypeptide comprising a tetrazine group, amino acid, bcn lysine, and pyirs trna synthetase
GT201200252A (en) OPTIMIZED MONOCLONAL ANTIBODIES AGAINST THE INHIBITOR OF THE TISSULAR FACTOR ROUTE (TFPI)
BR112019002505A2 (en) method for producing a recombinant protein aggregate, and recombinant protein aggregate.

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]